Eligible participants must provide informed consent and complete the necessary enrollment procedures outlined by the study protocol. The study coordinator or research team will assist you through the enrollment process.
Lung Cancer Resectable Stages II-IIIB
Exploring potential treatments for NSCLC by assessing the efficacy of the investigational drug in improving outcomes for patients with non-small cell lung cancer (NSCLC) after surgery.
Lung Cancer Resectable Stages Research & Clinical Trials
Lung cancer remains one of the most challenging diseases to treat, with advanced or metastatic NSCLC presenting particularly complex management scenarios. We are conducting a clinical trial at Hightower Clinical to evaluate a novel approach to treating previously untreated advanced or metastatic NSCLC.
The phase III study investigates whether the investigational drug offers better disease-free survival (DFS) for patients with NSCLC who did not achieve a pathological complete response (pCR) after neoadjuvant chemotherapy and surgery.
Condition
Non-Small Cell Lung Cancer
Current Status
Upcoming
Location
Oklahoma
Frequently Asked Questions
What is non-small cell lung cancer (NSCLC)?
NSCLC is a type of lung cancer that grows more slowly than small cell lung cancer. It is typically treated with surgery, chemotherapy, and immunotherapy, depending on the stage of the disease.
What are the potential benefits of participating in this study?
Participants in this paid study may gain access to promising new therapies at no cost and contribute to advancing lung cancer research.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.